ANXA5, annexin A5, 308

N. diseases: 283; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.040 Biomarker disease BEFREE Cytotoxicity and apoptotic potential were evaluated with an MTT assay and an annexin V-binding assay against the murine melanoma (B16F10), murine colon cancer (CT26), murine lung adenocarcinoma (3LL), and murine Ehrlich ascites carcinoma (EAC) cell lines. 28490010 2017
CUI: C0025202
Disease: melanoma
melanoma
0.040 AlteredExpression disease BEFREE Pure compounds and their complexes were tested for antiproliferative (MTT) and pro-apoptotic activity (Annexin V-PI) on the B164A5 murine melanoma cell line and for the antimicrobial properties (Disk Diffusion Method) on the selected strains. 27338298 2017
CUI: C0025202
Disease: melanoma
melanoma
0.040 Biomarker disease BEFREE Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma. 24743186 2014
CUI: C0025202
Disease: melanoma
melanoma
0.040 Biomarker disease BEFREE Annexin V staining confirmed that primary melanoma cells underwent apoptosis after treatment These experiments suggest that in situ hybridization of PAX3 on paraffin-embedded tissue may represent a novel means to identify melanoma cell lesions, which appear to become dependent on expression of this deregulated transcription factor. 11221862 2001